MX357132B - Use of inulin for treating clinical expressions associated to cirrhosis. - Google Patents
Use of inulin for treating clinical expressions associated to cirrhosis.Info
- Publication number
- MX357132B MX357132B MX2014001957A MX2014001957A MX357132B MX 357132 B MX357132 B MX 357132B MX 2014001957 A MX2014001957 A MX 2014001957A MX 2014001957 A MX2014001957 A MX 2014001957A MX 357132 B MX357132 B MX 357132B
- Authority
- MX
- Mexico
- Prior art keywords
- inulin
- cirrhosis
- expressions associated
- treating clinical
- clinical expressions
- Prior art date
Links
- 206010016654 Fibrosis Diseases 0.000 title abstract 2
- 229920001202 Inulin Polymers 0.000 title abstract 2
- 230000007882 cirrhosis Effects 0.000 title abstract 2
- 208000019425 cirrhosis of liver Diseases 0.000 title abstract 2
- 230000014509 gene expression Effects 0.000 title abstract 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 title abstract 2
- 229940029339 inulin Drugs 0.000 title abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002417 nutraceutical Substances 0.000 abstract 1
- 235000021436 nutraceutical agent Nutrition 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
The present invention describes and claims the use of inulin in the preparation of nutraceutical compositions useful as an adjuvant in the treatment of clinical expressions related to cirrhosis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2014001957A MX357132B (en) | 2014-02-19 | 2014-02-19 | Use of inulin for treating clinical expressions associated to cirrhosis. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2014001957A MX357132B (en) | 2014-02-19 | 2014-02-19 | Use of inulin for treating clinical expressions associated to cirrhosis. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014001957A MX2014001957A (en) | 2015-08-19 |
| MX357132B true MX357132B (en) | 2018-05-30 |
Family
ID=54598915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014001957A MX357132B (en) | 2014-02-19 | 2014-02-19 | Use of inulin for treating clinical expressions associated to cirrhosis. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX357132B (en) |
-
2014
- 2014-02-19 MX MX2014001957A patent/MX357132B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014001957A (en) | 2015-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202004557B (en) | Modulatory polynucleotides | |
| PH12015501648B1 (en) | 2-aminopyrimidine derivatives for the treatment of viral infections | |
| PL3349783T3 (en) | Compositions and methods relating to the treatment of diseases | |
| MX2022001105A (en) | Anti-tigit antibodies. | |
| PH12015502261A1 (en) | Macrocyclic deaza-purinones for the treatment of viral infections | |
| PH12014501738A1 (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
| PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
| PH12016501968A1 (en) | Novel macrocyclic compounds | |
| EP3134423A4 (en) | 2' -disubstituted nucleoside analogs for treatment of the flaviviridae family of viruses and cancer | |
| GB201404403D0 (en) | Compositions and methods relating to the treatment of diseases | |
| MX2017006026A (en) | Apilimod for use in the treatment of colorectal cancer. | |
| MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| MX2016008150A (en) | Berberine formulations and uses thereof. | |
| MX2016009056A (en) | Compositions and methods for treatment of abnormal cell growth. | |
| PH12016501434A1 (en) | Compositions for use in the treatment of allergic conditions | |
| EA201590615A1 (en) | STIMULATING LACTATION COMPOSITIONS BASED ON PHOSPHATIDIDILSERIN | |
| MY182818A (en) | Compositions for the treatment of fibrosis and fibrosis-related conditions | |
| MA40642A (en) | Novel peptide derivatives and uses thereof | |
| PT3548006T (en) | Composition for use in the treatment of intestinal alterations | |
| MX357132B (en) | Use of inulin for treating clinical expressions associated to cirrhosis. | |
| PH12017501147A1 (en) | Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs | |
| PH12017501693A1 (en) | Compositions for the treatment of kidney and/or liver diseases | |
| GB201516437D0 (en) | Compositions and methods relating to the treatment of disease | |
| GB201516303D0 (en) | Compositions and methods relating to the treatment of diseases | |
| IN2014MU00205A (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |